Mary Davis
Family · Central City, KYNPI 1144826298
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $416 and has fallen 63.4% since, to $152 in 2025.
Across 73 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- USWM, LLC$200
- AbbVie$154
- Braeburn Inc.$121
- Otsuka America Pharmaceutical, Inc.$80
- Takeda Pharmaceuticals U.S.A., Inc.$75
- Indivior Inc.$73
- plus $492 from 13 others
What the payments were for
- Food & beverage$1,196100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| USWM, LLC | 13 | $200 |
| AbbVie | 9 | $154 |
| Braeburn Inc. | 7 | $121 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $75 |
| Indivior Inc. | 5 | $73 |
| Almatica Pharma LLC | 4 | $66 |
| Corium, LLC | 4 | $63 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Lundbeck LLC | 3 | $53 |
| Novo Nordisk | 3 | $49 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $44 |
| Idorsia Pharmaceuticals US Inc | 3 | $40 |
| Gilead | 1 | $33 |
| Antares Pharma, Inc. | 2 | $29 |
| Corcept Therapeutics | 1 | $18 |
| Pfizer | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Alkermes, Inc. | 1 | $13 |
How this compares
$1,196 in reported general payments places this provider in the 65th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 12 | $16,321 |
| OzempicSemaglutide | 12 | $10,929 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $5,004 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 42 | $4,218 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $987 |
| Ventolin HfaAlbuterol Sulfate | 17 | $956 |
| Gabapentin | 55 | $496 |
| Levothyroxine Sodium | 21 | $322 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 13 | $299 |
| Omeprazole | 37 | $221 |
| Duloxetine Hcl | 30 | $216 |
| Lisinopril | 49 | $172 |
| Testosterone Cypionate | 15 | $144 |
| Pantoprazole Sodium | 27 | $140 |
| Atorvastatin Calcium | 25 | $114 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $154 | $16,32112 claims |
| Novo NordiskOzempic | $49 | $10,92912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,374 family providers in Kentucky.
Other family in Central City
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
- Carrie Parrish NyekanBowling Green$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.